Nuclear localization signal peptides enhance transfection efficiency of chitosan/DNA complexes delivery

The purpose of this study was to investigate the potential of nuclear localization signal (NLS) "KPKKKRKV" to mediate the in vitro transfection efficiency of chitosan (CS)/DNA complexes, aiming at its use in gene therapy applications. In the preparation of CS/DNA complexes containing NLS, peptide with NLS was directly incorporated without covalent conjugation to pDNA or chitosan. The gene transfer efficiency of CS/DNA complexes with and without NLS was evaluated in the human cervical carcinoma cell line (Hela cells). The CS/DNA complex containing NLS increased transfection efficiencies in a NLS-dose dependent manner on the Hela cells, compared to the control (CS/DNA complex or NLS). The highest transfection efficiency was significantly observed in CS/DNA complex at the weight ratio of 8 with 120 microg NLS and was 74-fold higher than that in the cells transfected with CS/DNA complex. Cytotoxicity of the NLS/CS/DNA complexes increased as the amount of the peptide increased, however, over 80% average cell viability was observed for complexes at the effective concentration of the peptide for transfections. Therefore, the NLS is expected to be a potent transfection enhancing agent without a covalent conjugation to pDNA or chitosan. Our findings suggest that the high gene expression with the negligible cytotoxicity can be achieved by adding the NLS peptide to chitosan/DNA complexes at an optimal ratio.

[1]  J. Wolff,et al.  A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. , 1999, Journal of cell science.

[2]  C. K. Chan,et al.  Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. , 1999, Human gene therapy.

[3]  J. Nah,et al.  Efficient gene delivery by urocanic acid-modified chitosan. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[4]  A. Logan,et al.  Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. , 2004, Bioconjugate chemistry.

[5]  C. Di Giorgio,et al.  Synthesis of acridine-nuclear localization signal (NLS) conjugates and evaluation of their impact on lipoplex and polyplex-based transfection. , 2005, European journal of medicinal chemistry.

[6]  P. Opanasopit,et al.  Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. , 2008, International journal of pharmaceutics.

[7]  J. Nah,et al.  Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[8]  A. Rolland.  Gene medicines: the end of the beginning? , 2005, Advanced drug delivery reviews.

[9]  F. Alexis,et al.  Low molecular weight polyethylenimines linked by β‐cyclodextrin for gene transfer into the nervous system , 2006, The journal of gene medicine.

[10]  J. Fernandes,et al.  Synthetic and natural polycations for gene therapy: state of the art and new perspectives. , 2006, Current gene therapy.

[11]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Ruozi,et al.  Cationic Liposomes for Gene Transfection , 2003, Journal of drug targeting.

[13]  M. Buschmann,et al.  High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. , 2006, Biomaterials.

[14]  D. Dean,et al.  Nuclear targeting of plasmid DNA in human corneal cells. , 1999, Current eye research.

[15]  P. Opanasopit,et al.  Methylated N-(4-pyridinylmethyl) chitosan as a novel effective safe gene carrier. , 2008, International journal of pharmaceutics.

[16]  P. Opanasopit,et al.  Methylated N-(4-N,N-dimethylaminobenzyl) chitosan as effective gene carriers: Effect of degree of substitution , 2009 .

[17]  Marie Carrière,et al.  NLS bioconjugates for targeting therapeutic genes to the nucleus. , 2003, Advanced drug delivery reviews.

[18]  P. Opanasopit,et al.  Chitosan lactate as a nonviral gene delivery vector in COS-1 cells , 2006, AAPS PharmSciTech.

[19]  C. Fong,et al.  Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[20]  N. M. Rao,et al.  The role of plasmid constructs containing the SV40 DNA nuclear-targeting sequence in cationic lipid-mediated DNA delivery. , 2005, Cellular & molecular biology letters.

[21]  R. Lockey,et al.  Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery , 2006, Pharmaceutical Research.

[22]  H. Yoo,et al.  Nuclear targeting of non-viral gene carriers using psoralen-nuclear localization signal (NLS) conjugates. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  Y. Okahata,et al.  Mechanism of cell transfection with plasmid/chitosan complexes. , 2001, Biochimica et biophysica acta.

[24]  M. Mano,et al.  S413‐PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA , 2008, The journal of gene medicine.

[25]  R. Cartier,et al.  Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems , 2002, Gene Therapy.

[26]  Byung-Soo Kim,et al.  Poly(l-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA , 2007, Journal of drug targeting.